fluorodeoxyglucose f18 has been researched along with Lymphoma, Follicular in 127 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (0.79) | 18.2507 |
2000's | 22 (17.32) | 29.6817 |
2010's | 73 (57.48) | 24.3611 |
2020's | 31 (24.41) | 2.80 |
Authors | Studies |
---|---|
Delmer, A; Durot, C; Durot, E; Godard, F; Hoeffel, C; Morland, D | 1 |
Li, F; Luo, Y; Yang, Q; Zhang, W; Zhang, Y; Zhou, D | 1 |
Blum, KA; Dimier, N; Dixon, JG; Evens, AM; Federico, M; Marcus, R; Morschhauser, F; Nielsen, T; Shi, Q; Zheng, J | 1 |
Akagi, A; Ando, T; Fujino, M; Goto, Y; Ito, A; Ito, M; Iwasaki, Y; Kamoshita, S; Katsuno, M; Mano, K; Miyahara, H; Miyamura, K; Ozawa, Y; Riku, Y; Yoshida, M | 1 |
Kokkonen, SM; Kuittinen, O; Kuitunen, H; Rajamäki, A; Sorigue, M; Sunela, K | 1 |
Annunziata, S; D'Alò, F; Giordano, A; Hohaus, S; Leccisotti, L; Maccora, D; Maiolo, E; Malafronte, R; Rufini, V | 1 |
Barna, S; Illés, Á; Jóna, Á; Kenyeres, A; Simon, Z | 1 |
Cheah, CY; Salvaris, RT | 1 |
Andreu, R; Baile, M; Balaguer, A; Benet, C; Celades, C; Chen-Liang, T; Contreras, J; Cortes, M; Fernández-González, M; Frutos, L; Jerez, A; López-Jiménez, J; Marquet-Palomanes, J; Martin García-Sancho, A; Martín-Santos, T; Martínez-Garcia, AB; Mucientes, J; Navarro, JL; Navarro, JT; Ortuño, FJ; Pérez-Ceballos, E; Reguilón-Gallego, L; Ródenas-Quiñonero, I; Ruiz, C; Salar, A; Sánchez-Blanco, JJ; Sopena-Novales, P; Suarez, M; Tamayo, P; Terol, MJ; Teruel, AI; Uña, J | 1 |
Du Guesclin, A; Gaylard, A; Goai, XY; Hodgson, R | 1 |
Qiao, W; Sun, N; Wang, T; Xing, Y; Zhao, J | 1 |
Sang, S; Zhang, B; Zhou, Y | 1 |
Procházka, V | 1 |
Chen, D; Liu, J; Nuermaimaiti, R; Si, J; Tian, C; Xue, Q; Zheng, Y | 1 |
Choi, HJ; Jo, JC; Lee, YJ; Park, SH; Seo, M | 1 |
Cheng, W; Feng, J; He, D; Qi, S; Xu, C; Yue, Y; Zhang, G | 1 |
Ahmed, MA; Cheah, C; Davis, RE; Fayad, LE; Feng, L; Fowler, NH; Hagemeister, FB; Nastoupil, LJ; Neelapu, SS; Noorani, M; Rodriguez, A; Romaguera, JE; Samaniego, F; Strati, P; Wang, M; Westin, JR | 1 |
Cobo-Rodríguez, A; Infante-de-la-Torre, JR; Jiménez-Granero, P; Martín-Marcuartu, JJ; Martínez-Esteve, A; Moreno-Caballero, M; Rayo-Madrid, JI; Serrano-Vicente, J | 1 |
Belmonte, G; Caldarella, C; Hohaus, S; Manfredi, R; Minordi, LM | 1 |
Cao, X; Li, F; Li, J; Luo, Y; Pan, Q | 1 |
Mikhaeel, NG | 1 |
Broski, SM; Habermann, TM; LaPlant, BR; Macon, WR; Maurer, MJ; Ristow, K; St-Pierre, F; Thanarajasingam, G; Witzig, TE | 1 |
Batlevi, CL; Dogan, A; Mauguen, A; Michaud, L; Moskowitz, AJ; Nakajima, R; Schöder, H | 1 |
Alpár, D; Balogh, A; Bátai, B; Bödör, C; Illés, S; Kiss, L; Kotmayer, L; Masszi, A; Masszi, T; Matolcsy, A; Mikala, G; Nagy, Á; Nagy, N | 1 |
Brunel, V; Chiche, L; Cohen, F; Pegliasco, H; Rebaudet, S | 1 |
Gemdzhian, EG; Kovrigina, AM; Krasil'nikova, IV; Kravchenko, SK; Lutsik, NS; Nesterova, ES; Sudarikov, AB; Yatsyk, GA | 1 |
Barrington, SF; Trotman, J | 1 |
Bird, RJ; Cross, D; de Long, LM; Gandhi, MK; Gunawardana, J; Halliday, SJ; Hernandez, A; Jain, S; Keane, C; Law, P; Law, SC; Nath, K; Sabdia, MB; Sester, D; Shanavas, M; Talaulikar, D; Tobin, JWD; Trotman, J; Tsang, H | 1 |
Chen, X; Wang, S; Wang, X; Wei, M; Yang, Z | 1 |
Pettitt, AR; Trotman, J | 1 |
Barton, H; Charles-Edwards, E; Chevassut, T; Dizdarevic, S; Teagle, AR | 1 |
Adams, HJA; Kwee, TC | 3 |
Avivi, I; Bentur, OS; Dally, N; Gafter-Gvili, A; Ganzel, C; Gatt, M; Gurion, R; Gutwein, O; Herishanu, Y; Horowitz, NA; Kreiniz, N; Paltiel, O; Perry, C; Raanani, P; Ram, R; Sarid, N; Shvidel, L | 1 |
Brousset, P; Franchet, C; Hitzel, A; Martin-Blondel, G; Péricart, S | 1 |
Annunziata, S; Cuccaro, A; Hohaus, S; Rufini, V; Tisi, MC | 1 |
Cairoli, A; Grandoni, F; Martins, F; Stalder, G; Van Der Gucht, A | 1 |
Bressel, M; Hicks, RJ; Khor, R; MacManus, M; Ng, SP; Seymour, JF; Wirth, A | 1 |
Aleman, BMP; Andraos, TY; Balogh, A; Binkley, MS; Brady, JL; Bratman, SV; Chau, K; Chelius, M; Choi, SH; Constine, LS; Dabaja, B; Eich, HT; El-Galaly, TC; Filippi, AR; Hajj, C; Hardy, S; Hodgson, DC; Hoppe, RT; Jones, M; Kirova, Y; Levis, M; Mac Manus, M; Mikhaeel, NG; Ng, AK; Oguchi, M; Reinartz, G; Ricardi, U; Suh, CO; Vistisen, AK; Wirth, A; Yahalom, J | 1 |
Sancho, JM; Sorigue, M | 1 |
Barrington, SF; Meignan, M; Trotman, J | 1 |
Montoto, S | 1 |
Bolzacchini, E; Campiotti, L; Casagrande, S; DE Palma, D; Guasti, L; Ogliari, F; Proserpio, I; Schiorlin, I; Squizzato, A; Suter, M | 1 |
Ahmed, S; Aleman, BMP; Andraos, TY; Balogh, A; Binkley, MS; Brady, JL; Bratman, SV; Chau, K; Chelius, M; Choi, SH; Constine, LS; Dabaja, B; Eich, HT; El-Galaly, TC; Filippi, AR; Hajj, C; Hardy, S; Hodgson, DC; Hoppe, RT; Jones, M; Kirova, YM; Levis, M; MacManus, M; Mikhaeel, NG; Ng, AK; Oguchi, M; Reinartz, G; Ricardi, U; Suh, CO; Vistisen, AK; Wirth, A; Yahalom, J | 1 |
Cao, L; Ding, CY; Fan, L; Li, JY; Li, TN; Liang, JH; Wang, L; Wu, W; Xia, J; Xu, W; Zhang, YP; Zhu, HY | 1 |
Ansell, SM; Broski, SM; Habermann, TM; LaPlant, BR; Macon, WR; Maurer, MJ; Micallef, INM; Nowakowski, GS; Ristow, K; St-Pierre, F; Thompson, CA; Witzig, TE | 1 |
Hatazawa, J; Isohashi, K; Kanakura, Y; Kato, H; Matsunaga, K; Tatsumi, M; Watabe, T | 1 |
Bosco, A; Dhiantravan, N; Hovey, E; Wegner, EA | 1 |
Arcaini, L; Biasoli, I; Boccomini, C; Carella, AM; D'Arco, AM; Di Raimondo, F; Federico, M; Ferreri, AJ; Gaidano, G; Gallamini, A; Luminari, S; Mastronardi, S; Merli, F; Musto, P; Rusconi, C; Santoro, A; Spina, M; Versari, A; Zinzani, PL | 1 |
Hofman, MS; Seymour, JF; Trotman, J | 1 |
Abbas, A; Barré, L; Dhilly, M; Dumontet, C; Fillesoye, F; Galateau, F; Gourand, F; Guillouet, S; Leporrier, M; MacKenzie, ET; Patin, D; Tirel, O | 1 |
Brown, JR; Jacene, HA; Pyo, J; Sakellis, CG; Van den Abbeele, AD; Won Kim, K | 1 |
Fang, Y; Huang, WT; Li, XM; Liang, Y; Liu, Y; Wu, N; Zhang, H; Zhang, WJ; Zheng, R | 1 |
Bacci, F; Castrovinci, S; Cefarelli, M; Di Bartolomeo, R; Di Eusanio, M; Leone, O; Lovato, L; Nanni, C; Ortolani, P; Rapezzi, C; Zinzani, P | 1 |
Gönen, M; Lilienstein, J; Maragulia, J; Moskowitz, CH; Ulaner, GA; Zelenetz, AD | 1 |
El-Najjar, I; Gribben, J; Matthews, J; McDowell, A; Montoto, S; Szyszko, TA | 1 |
Balzarotti, M; Biasoli, I; Boccomini, C; Bottelli, C; Carella, AM; Federico, M; Ferreri, AJ; Franceschetti, S; Franceschetto, A; Gallamini, A; Luminari, S; Merli, F; Micol, Q; Musto, P; Raimondo, FD; Rattotti, S; Rusconi, C; Salvi, F; Spina, M; Versari, A; Zinzani, PL | 1 |
Fukayama, M; Hosoi, A; Kurokawa, M; Nakamura, F; Nakazaki, K; Nannya, Y; Shinozaki-Ushiku, A; Uni, M; Yoshimi, A | 1 |
Fournier, M; Fulham, M; Lamy, T; Meignan, M; Ricard, F; Salles, G; Trotman, J; Tychyj-Pinel, C; Vera, P | 1 |
Adams, HJ; Blase, PE; de Klerk, JM; Dubois, SV; Fijnheer, R; Kwee, TC; Nievelstein, RA | 1 |
Chong, S; Downe, P; Lin, M; Ling, S; Lu, Z | 1 |
Hussey, D; Metser, U; Murphy, G | 1 |
Macdonald, WB; McQuillan, AD; Turner, JH | 1 |
Luminari, S; Trotman, J | 1 |
Dunleavy, K; Redman, M; Smith, SD | 1 |
Boellaard, R; Chamuleau, ME; Cillessen, SA; Hoekstra, OS; Hoetjes, N; Jauw, Y; Regelink, JC; Rizvi, SN; van de Ven, PM; Wondergem, MJ; Zijlstra, JM; Zweegman, S | 1 |
Adams, HJ; Kwee, TC; Nievelstein, RA | 2 |
Akyel, R; Ekmekcioglu, O; Ozbayrak, M; Sonmezoglu, K; Vatankulu, B | 1 |
Anastasia, A; Biasoli, I; Federico, M; Ferrari, A; Galimberti, S; Luminari, S; Manni, M; Petrini, M; Rusconi, C; Versari, A | 1 |
Ding, CY; Li, TN; Sun, J; Xu, W | 1 |
Adams, HJA; Kwee, TC; Nievelstein, RAJ | 1 |
Huang, J; Xie, P | 1 |
Amit, O; Avivi, I; Ben-Ezra, J; Even-Sapir, E; Herishanu, Y; Joffe, E; Kesler, M; Lerman, H; Perry, C; Sarid, N | 1 |
Barrington, SF; Mikhaeel, NG | 2 |
Cheson, BD; Cordova, C; Esposito, G; Hill, EM; Nassif, S; Ozdemirli, M; Ujjani, CS; Wang, H | 1 |
Baetz, T; Berge, C; Buckstein, R; Caballero, D; Crump, M; Fine, G; Fingerle-Rowson, G; Gaidano, G; Goy, A; Kostakoglu, L; Martinelli, G; Press, O; Sahin, D; Sehn, L | 1 |
Hsieh, TC; Kao, CH; Liao, CW; Yen, KY | 1 |
Byrtek, M; Dawson, KL; Flowers, CR; Friedberg, JW; Reid, E; Wong-Sefidan, I; Zelenetz, AD; Zhou, X | 1 |
Adams, HJ; Kwee, TC | 1 |
Afaq, A; Akin, O; Ardeshna, K; Chen, SH; Fraioli, F; Groves, A; Kayani, I; Lambert, J; Linch, D; Miles, K; Punwani, S; Sidhu, H; Wan, S | 1 |
Flowers, CR; Howard, DH; Lee, D; Lipscomb, J; Nastoupil, LJ; Rai, A; Ward, KC; Williams, JN | 1 |
Hofman, MS; Ravi Kumar, AS; Tam, C | 1 |
Cabezas-Herrera, J; Monserrat-Coll, JL; Nicolás-Ruiz, F; Piñero-Madrona, A; Ruiz-Pardo, J | 1 |
Alinari, L; Baccarani, M; Derenzini, E; Fanti, S; Gandolfi, L; Musuraca, G; Stefoni, V; Tani, M; Venturini, F; Zinzani, PL | 1 |
Bolcak, K; Janikova, A; Kral, Z; Mayer, J; Pavlik, T | 1 |
Il'in, NV; Ivanova, AA; Ivanova, EI; Ryzhkova, DV; Savchenko, ON; Tiutin, LA; Tlostanova, MS; Vinogradova, IuN | 1 |
Asaka, M; Hashino, S; Imamura, M; Kahata, K; Kondo, T; Kubota, K; Matsuno, Y; Morita, R; Onozawa, M; Suzuki, S | 1 |
Adams, JL; Elner, VM; Flint, A; Pynnonen, MA; Smith, LB | 1 |
Abrisqueta, P; Fuertes, S; Fuster, D; Lafuente, S; López-Guillermo, A; Mena, LM; Pons, F; Rodríguez, S; Rubí, S; Setoain, X | 1 |
Takada, M; Yamamoto, S | 1 |
Bellò, M; Bertagna, F; Botto, B; Derenzini, E; Fanti, S; Fonti, C; Huglo, D; Lopci, E; Morschhauser, F; Santi, I; Savelli, G; Zinzani, P | 1 |
Bahri, H; Barge, ML; Bayat, S; Cuggia, M; De Guibert, S; Devillers, A; Garin, E; Houot, R; Lamy, T; Le Dortz, L; Le Jeune, F; Rolland, Y | 1 |
Castellucci, P; Fanti, S; Fonti, C; Lopci, E; Maffione, AM; Montini, G; Rubello, D; Santi, I; Stefoni, V; Tani, M; Zinzani, P | 1 |
Hickeson, M; Makis, W; Novales-Diaz, JA | 1 |
Ballek, E; Grgic, A; Hellwig, D; Hohloch, K; Kirsch, CM; König, J; Nestle, U; Pinkert, J; Puskas, C; Scheidhauer, K; Schubert, J; Truemper, L | 1 |
Ishizawa, K; Ogura, M; Tateishi, U; Tatsumi, M; Terauchi, T; Tobinai, K | 1 |
Hicks, RJ; Hofman, MS | 1 |
Hoppe, RT | 1 |
Chiti, A; Fanti, S; Fonti, C; Lopci, E; Santi, I; Zanoni, L; Zinzani, PL | 1 |
Hara, M; Kohashi, S; Miyagawa, M; Miyazaki, Y; Nakase, K; Nawa, Y | 1 |
Catalano, PJ; Halasz, LM; Jacene, HA; Lacasce, A; Mauch, PM; Ng, AK; Van den Abbeele, AD | 1 |
Almeida, LY; Almeida, OP; Feio, Pdo S; Gomes, CB; León, JE; Nogueira, AS; Soares, FA; Vassallo, J | 1 |
Berenger, N; Berriolo-Riedinger, A; Brice, P; Casasnovas, RO; Colombat, P; Dupuis, J; Feugier, P; Gallamini, A; Haioun, C; Julian, A; Laurent, G; Meignan, M; Mounier, N; Paone, G; Salles, G; Soubeyran, P; Tilly, H; Tychyj-Pinel, C; Vera, P; Xerri, L | 1 |
Araki, M; Fujiki, S; Imagawa, A; Inaba, T; Iwamuro, M; Kawahara, Y; Kawai, Y; Mizuno, M; Morito, T; Nishimura, M; Okada, H; Shinagawa, K; Shiode, J; Suzuki, S; Takaki, A; Takata, K; Yamamoto, K; Yoshino, T | 1 |
Fukayama, M; Hangai, S; Ichikawa, M; Kamikubo, Y; Koike, K; Kurokawa, M; Nakamura, F; Suzuki, H; Takazawa, Y; Yamada, A; Yoshida, S | 1 |
Bailly, C; Bodet-Milin, C; Dupas, B; Eugène, T; Gastinne, T; Kraeber-Bodéré, F; Le Gouill, S | 1 |
Abel, GA; Abou-Nassar, KE; Crosby, A; Czuczman, MS; Friedberg, JW; Gordon, LI; Kaminski, M; Lacasce, AS; Millenson, M; Niland, J; Rodriguez, MA; Vanderplas, A; Zelenetz, AD | 1 |
Brink, I; Hoegerle, S; Schneider, B | 1 |
Blum, RH; Hicks, RJ; MacManus, M; Seymour, JF; Wirth, A | 1 |
Bridwell, RS; Montilla-Soler, JL; Rexroad, JT | 1 |
Chott, A; Hoffmann, M; Jäger, U; Kletter, K; Püspök, A; Raderer, M | 1 |
Alavi, A; Bhargava, P; Kumar, R; Schuster, SJ; Yu, JQ; Zhuang, H | 1 |
Avril, N; Degirmenci, B; Jacobs, S; Joyce, JM; McCook, B | 1 |
Chan-Kai, BT; Yen, MT | 1 |
Becherer, A; Hauswirth, A; Hoffmann, M; Jaeger, U; Kletter, K; Raderer, M; Turetschek, K; Wöhrer, S | 1 |
Ali, A; Cyriac, J; Karam, M; Nazeer, T; Novak, L; Nugent, F | 1 |
Lu, MT; Menard, MT; Millstine, J; Rybicki, FJ; Viscomi, S | 1 |
Wooldridge, JE | 1 |
Baudard, M; Comte, F; Conge, AM; Klein, B; Mariano-Goulart, D; Rossi, JF | 1 |
Castaldi, P; Maussier, ML; Melis, L; Perotti, G; Rubello, D; Rufini, V; Salvatori, M | 1 |
Wirth, A | 1 |
Armitage, JO; Bishu, S; Bishu, SR; Hankins, JH; Holdeman, KP; Olsasky, SM; Paknikar, S; Quigley, JM; Shostrom, VK; Stem, RA | 1 |
Foo, M; Hicks, RJ; Macmanus, MP; Seymour, JF; Wirth, A | 1 |
Arimizu, N; Imazeki, K; Itami, J; Kuyama, J; Maruno, H; Minoshima, S; Okada, J; Uno, K; Yoshikawa, K | 1 |
12 review(s) available for fluorodeoxyglucose f18 and Lymphoma, Follicular
Article | Year |
---|---|
Histological transformation of follicular lymphoma demonstrated by PET/CT-guided re-biopsy of FDG-avid lesions: A case report and literature review.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Positron emission tomography to detect bone marrow involvement for patients with follicular lymphoma: a systematic review and meta-analysis.
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron Emission Tomography Computed Tomography | 2023 |
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography | 2021 |
End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Patient Outcome Assessment; Positron-Emission Tomography; Proportional Hazards Models; Radioimmunotherapy; Radiopharmaceuticals; Treatment Outcome | 2013 |
Impact of (18)F-FDG PET/CT on the staging and management of follicular lymphoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2014 |
FDG PET-CT in follicular lymphoma: a case-based evidence review.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Lymphoma, Follicular; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis | 2015 |
Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.
Topics: Biological Transport; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2015 |
Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron-Emission Tomography; Prognosis; Prospective Studies; Retrospective Studies | 2016 |
PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Survival Rate; Tomography, X-Ray Computed | 2016 |
Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Imaging in follicular NHL.
Topics: Biopsy, Needle; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
Treatment strategies in limited stage follicular NHL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiotherapy; Radiotherapy Dosage; Treatment Outcome | 2011 |
11 trial(s) available for fluorodeoxyglucose f18 and Lymphoma, Follicular
Article | Year |
---|---|
Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphoma.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Spleen; Survival Rate | 2019 |
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Italy; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Vincristine | 2013 |
Phase II study of first-line (131)I-rituximab radioimmunotherapy in follicular non-Hodgkin lymphoma and prognostic (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Radioimmunotherapy; Rituximab; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.
Topics: Adult; Aged; Area Under Curve; Biomarkers, Tumor; Biopsy; Cell Transformation, Neoplastic; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Follicular; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Remission Induction; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm, Residual; Oncogene Proteins, Fusion; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Real-Time Polymerase Chain Reaction; Recurrence | 2016 |
FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome | 2017 |
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Vincristine | 2008 |
Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter study.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Clinical Trials, Phase II as Topic; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2011 |
Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Prospective Studies; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2012 |
18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum.
Topics: Adult; Aged; Duodenal Neoplasms; Duodenoscopy; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Importance of [18F]fluorodeoxyglucose-positron emission tomography scanning for the monitoring of responses to immunotherapy in follicular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Combined Modality Therapy; Dendritic Cells; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphoma, Follicular; Male; Middle Aged; Neoplasm, Residual; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed | 2007 |
104 other study(ies) available for fluorodeoxyglucose f18 and Lymphoma, Follicular
Article | Year |
---|---|
Cerebellum/liver index in pretherapeutic 18F-FDG PET/CT as a predictive marker of progression-free survival in follicular lymphoma treated by immunochemotherapy and rituximab maintenance.
Topics: Biomarkers; Cerebellum; Fluorodeoxyglucose F18; Humans; Immunotherapy; Liver; Lymphoma, Follicular; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Rituximab | 2022 |
Baseline [
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, Follicular; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron-Emission Tomography; Progression-Free Survival; Randomized Controlled Trials as Topic; Remission Induction | 2022 |
Neurolymphomatosis in follicular lymphoma: an autopsy case report.
Topics: Autopsy; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Lymphoma, Follicular; Middle Aged; Neurolymphomatosis | 2022 |
FDG-PET/CT-guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden.
Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Time-to-Treatment; Tumor Burden; Watchful Waiting | 2023 |
Clinical and biological prognostic factors in follicular lymphoma patients.
Topics: Biological Factors; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Time to omit interim CT imaging during frontline chemoimmunotherapy for patients with follicular lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Rituximab; Tomography, X-Ray Computed | 2022 |
Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study.
Topics: Biopsy; Bone Marrow; Cohort Studies; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2023 |
PET-positive suture granuloma of abdominal wall 56 years post-appendicectomy mimicking recurrence of lymphoma.
Topics: Abdominal Wall; Fluorodeoxyglucose F18; Foreign-Body Reaction; Granuloma; Humans; Lymphoma, Follicular; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sutures | 2023 |
Prognostic value of interim
Topics: Adult; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2023 |
Interim PET in follicular lymphoma: more patience, please.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2023 |
A Case of Adenomyosis Showing Size Reduction in a Follicular Lymphoma Patient Receiving Chemotherapy With R-Bendamustine.
Topics: Adenomyosis; Bendamustine Hydrochloride; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
A hybrid few-shot multiple-instance learning model predicting the aggressiveness of lymphoma in PET/CT images.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2024 |
Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Follicular; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2020 |
Aggressive cutaneous follicular lymphoma in a
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Muscle Recurrence of a Primarily Nodal Follicular Lymphoma Studied by Contrast-Enhanced 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Middle Aged; Muscle Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Posttreated POEMS Syndrome With Concurrent Follicular Lymphoma Revealed by 18F-FDG and 68Ga-Pentixafor PET/CT.
Topics: Coordination Complexes; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Peptides, Cyclic; POEMS Syndrome; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Hotter is not more aggressive: baseline SUVmax in FL.
Topics: Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, Follicular; Positron-Emission Tomography | 2020 |
Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma.
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information.
Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2020 |
Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma.
Topics: Aged; Biomarkers, Tumor; Circulating Tumor DNA; DNA Mutational Analysis; Enhancer of Zeste Homolog 2 Protein; Female; Fluorodeoxyglucose F18; Humans; Liquid Biopsy; Lymphoma, Follicular; Male; Middle Aged; Mutation | 2020 |
[Incidental pneumonia on PET imaging].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asymptomatic Diseases; Carrier State; COVID-19; Diagnosis, Differential; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Follicular; Male; Pneumonia, Viral; Positron-Emission Tomography | 2021 |
[Informativeness of whole-body diffusion-weighted magnetic resonance imaging and positron emission tomography with computed tomography in follicular lymphoma].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies | 2020 |
Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2021 |
Characterizing Concomitant Follicular Lymphoma and Gastric Carcinoma Using 68Ga-FAPI-04 and 18F-FDG PET/CT.
Topics: Aged; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Positron Emission Tomography Computed Tomography; Quinolines | 2022 |
Is it time for PET-guided therapy in follicular lymphoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; COVID-19; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Follicular; Outcome Assessment, Health Care; Pandemics; Positron Emission Tomography Computed Tomography; Prednisone; Prospective Studies; Rituximab; SARS-CoV-2; Vincristine | 2022 |
Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
Topics: Adult; Aged; Biopsy; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ilium; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Debate on the value of end-of-treatment FDG-PET response evaluation in follicular lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Recurrence; Research Design; Survival Analysis; Treatment Outcome | 2017 |
Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy; Retrospective Studies; Survival Rate | 2018 |
Assessing complete remission status in incurable follicular lymphomas, to what purpose?
Topics: Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron-Emission Tomography | 2019 |
18F-Fluorodeoxyglucose positron emission tomography computed tomography detection threshold in follicular lymphoma: A case report.
Topics: Adrenal Cortex Hormones; Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Germinal Center; Humans; Lymphoma, Follicular; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUV
Topics: Antineoplastic Agents; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Kaplan-Meier Estimate; Liver; Lymphoma, Follicular; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2018 |
Intramuscular Follicular Lymphoma.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography | 2018 |
Outcome of patients with early-stage follicular lymphoma staged with
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals | 2019 |
Definitive radiotherapy for localized follicular lymphoma staged by
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Retrospective Studies; Survival Rate; Young Adult | 2019 |
Further Examining the TROG 99.03 Trial in Early-Stage Follicular Lymphoma: Cure Rate and the Role of Positron Emission Tomography.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron-Emission Tomography | 2019 |
Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma?
Topics: Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, Follicular; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2019 |
Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma? - Authors' reply.
Topics: Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, Follicular; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2019 |
Localized FL: how long in response to be cured?
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron Emission Tomography Computed Tomography | 2019 |
Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-center experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Survival Analysis; Tumor Burden; Vincristine | 2021 |
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Progression-Free Survival; Radiopharmaceuticals; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Time Factors; Vincristine; Watchful Waiting; Young Adult | 2019 |
Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT in Patients with Follicular Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; ROC Curve; Sensitivity and Specificity; Survival Analysis; Tumor Burden | 2019 |
Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2019 |
Concomitant Prostate Carcinoma and Follicular Lymphoma: "Flip-Flop" Appearances on PSMA and FDG PET/CT Scans.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lysine; Male; Neoplasm Metastasis; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea | 2019 |
Evaluating the place of 18-fluoro-2-deoxy-D-glucose positron emission tomography scanning in primary staging and beyond in patients with follicular lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Positron-Emission Tomography | 2013 |
2-[18F]fludarabine, a novel positron emission tomography (PET) tracer for imaging lymphoma: a micro-PET study in murine models.
Topics: Adult; Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Mice; Mice, SCID; Positron-Emission Tomography; Radiometry; Tissue Distribution; Vidarabine | 2014 |
[Correlation of ¹⁸F-FDG uptake with tumor-proliferating antigen Ki-67 expression in aggressive lymphoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies | 2013 |
Reactive follicular lymphoid infiltrate: a new condition to exclude in patients with PET positivity inside the heart.
Topics: Adult; Coronary Artery Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphoma, Follicular; Male; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2014 |
False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Topics: Adolescent; Adult; Aged; Child; Disease-Free Survival; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Transplantation, Autologous; Transplantation, Homologous | 2014 |
The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL).
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2014 |
Transformation of follicular lymphoma in the retroperitoneal muscles demonstrated by CT-guided needle biopsy of FDG-avid lesions; case series.
Topics: Aged; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study.
Topics: Case-Control Studies; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2014 |
The prognostic value of mid- and post-treatment [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Time Factors; Treatment Outcome | 2014 |
Positron emission tomography-computed tomography in follicular lymphoma: "one fit for all"?
Topics: Antibodies, Monoclonal, Murine-Derived; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography | 2015 |
FDG PET/CT Imaging of an Isolated Recurrence in the Eyelid of a Patient With Follicular Lymphoma.
Topics: Aged, 80 and over; Eye Neoplasms; Eyelids; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Multimodal Imaging; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
[Prognostic Value of Maximum Standard Uptake on Pretreatment ¹⁸F-FDG PET/CT Scan in Newly Diagnosed Follicular Lymphoma].
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Positron-Emission Tomography; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2015 |
Massive Pelvic Lymphadenopathy Due to Recurrent Non-Hodgkin Lymphoma Incidentally Revealed on a 99mTc-MDP Bone Scintigraphy.
Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals; Scrotum; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Urinary Bladder | 2016 |
The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma.
Topics: Biopsy; Bone Marrow Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2016 |
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2016 |
Zosteriform Secondary Cutaneous Diffuse Large B-Cell Lymphoma on FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2016 |
[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Rituximab; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
No convincing evidence to support postinduction FDG-PET in follicular lymphoma.
Topics: Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymphoma, Follicular; Positron-Emission Tomography | 2016 |
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Marrow Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Splenic Neoplasms; Young Adult | 2017 |
Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patients.
Topics: Aged; Aged, 80 and over; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Neoplasm Staging; Population Surveillance; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Proportional Hazards Models; SEER Program | 2017 |
FDG PET in follicular lymphoma: more than a staging test?
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
PET-CT gamma probe-guided lymph node biopsy: a new diagnostic surgical approach.
Topics: Fluorodeoxyglucose F18; Gamma Rays; Humans; Lymph Nodes; Lymphadenopathy; Lymphoma, Follicular; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma?
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Regression, Spontaneous; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome | 2008 |
[Role of 18F-FDG PET in tumor grading and evaluating effectiveness of therapy in malignant lymphomas].
Topics: Adult; Aged; Female; Fibrosis; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Spiral Computed; Treatment Outcome | 2008 |
Donor cell-derived sarcoidosis after allogeneic BMT.
Topics: Bone Marrow Transplantation; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Follicular; Middle Aged; Prognosis; Radiopharmaceuticals; Remission Induction; Sarcoidosis; Transplantation, Homologous; Treatment Outcome | 2009 |
Progressive eyelid and facial swelling due to follicular lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Disease Progression; Edema; Eyelid Diseases; Facial Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Histological transformation of follicular lymphoma after treatment: a case evaluated with PET/CT.
Topics: Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Gastric follicular lymphoma with mediastinal lymph node dissemination detected by FDG-PET.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Follicular; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Stomach Neoplasms | 2010 |
FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: multicentric study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radioimmunotherapy; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Immunologic Factors; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radioimmunotherapy; Radiopharmaceuticals; Yttrium Radioisotopes | 2010 |
Interesting image. Unsuspected synchronous thyroid carcinoma revealed on a post-therapy F-18 FDG PET/CT, in a patient with follicular lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma, Follicular; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Humans; Internet; Lymphoma, Follicular; Male; Middle Aged; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
FDG PET/CT predictive role in follicular lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
[Follicular lymphoma showing long-term false positive results by FDG-PET after rituximab-containing chemotherapy].
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Remission Induction; Rituximab; Time Factors; Vincristine | 2012 |
Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Rituximab; Treatment Failure; Vincristine; Young Adult | 2012 |
Reactive tonsillar enlargement showing strong 18F-FDG uptake during the follow-up of follicular lymphoma.
Topics: Adult; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperplasia; Lymphoma, Follicular; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tonsillar Neoplasms | 2013 |
Imaging follicular lymphoma using positron emission tomography with [(18)F]fluorodeoxyglucose: to what purpose?
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Positron-Emission Tomography | 2012 |
Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
Topics: Adult; Aged; Chi-Square Distribution; Endoscopy, Gastrointestinal; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Japan; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2012 |
Primary gastrointestinal follicular lymphoma with histological transformation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Duodenal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Intestinal Polyps; Lymphoma, Follicular; Male; Middle Aged; Oncogene Proteins, Fusion; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Remission Induction; Rituximab; Vincristine | 2013 |
The role of FDG-PET scanning in assessing lymphoma in 2012.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; France; Hodgkin Disease; Humans; Immunotherapy; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes databa
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Registries; Treatment Outcome; Young Adult | 2013 |
Enormous bilateral adrenal uptake of F-18 FDG caused by non-Hodgkin's lymphoma.
Topics: Adrenal Gland Neoplasms; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma.
Topics: False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Tc-99m depreotide scintigraphy of low-grade non-Hodgkin's lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Middle Aged; Neoplasm Staging; Organotechnetium Compounds; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2003 |
Spontaneous regression of follicular, mantle cell, and diffuse large B-cell non-Hodgkin's lymphomas detected by FDG-PET imaging.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Regression, Spontaneous; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
FDG PET CT assessment of treatment response after yttrium-90 ibritumomab tiuxetan radioimmunotherapy.
Topics: Antibodies, Monoclonal; Antigens, CD20; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Radioimmunotherapy; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Combined positron emission tomography/computed tomography imaging of orbital lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Orbital Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2005 |
18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas.
Topics: Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2006 |
Periaortic lymphoma as a mimic of posttraumatic intramural hematoma.
Topics: Accidents, Traffic; Aged, 80 and over; Aorta, Thoracic; Axilla; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Hematoma; Humans; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Can a positive positron emission tomography scan be positive news?
Topics: Cancer Vaccines; Combined Modality Therapy; Dendritic Cells; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphoma, Follicular; Neoplasm, Residual; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule | 2007 |
PET for follicular lymphoma: a work in progress!
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2008 |
The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Tomography, Emission-Computed | 1991 |